Signals flagged in the original
Analyzed by our bias model Full breakdown ↓
An analysis has found that proposed regulations from the Trump administration could potentially result in the cancellation of around 5,000 clinical trials. These regulations would grant political appointees final decision-making power over research grants.
Our neutral summary
An analysis has found that proposed regulations from the Trump administration could potentially result in the cancellation of around 5,000 clinical trials. These regulations would grant political appointees final decision-making power over research grants.
The reporting belongs to Scientific American; we don't reproduce it.
No note attached
on this article.
Proposed White House regulations could kill 5,000 clinical trials, analysis finds
Analysis suggests proposed regulations could impact clinical trials